Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Molecular carcinogenesis Wiley Volume:
Keywords : Serum lncRNAs, NBAT‐1, , FOXCUT signature in hepatocellular    
Abstract:
Background: Hepatocellular Carcinoma (HCC) is a universal health problem responsible for 8.2% of all cancer deaths. Numerous risk factors were documented to be contributed to HCC development with viral hepatitis C ranking as the major predisposing factor in Egypt. The presence of a detectable amount of long noncoding RNAs (lncRNAs) in the circulation is linked to the development and spread of tumors. LncRNAs NBAT‐1 and FOXCUT expression levels were used as genetic markers for the detection of gastrointestinal tract cancers. We hypothesized that serum expression levels of NBAT‐1 and FOXCUT are new biomarkers for HCC that are related to laboratory and pathological markers. Patients and Methods: This study included 165 hepatitis C virus (HCV)‐related HCC Egyptian patients, 180 HCV‐infected noncancer patients, and 180 healthy controls, the serum expression levels of NBAT‐1 and FOXCUT were measured by using quantitative real‐time polymerase chain reaction. Results: This study's results include that medians (inter‐quartile range [IQRs]) of NBAT‐1 in HCC and HCV patients were (1.9 [0.87−4.94], 10.01 [7.34−13.29] respectively) which exhibited significantly higher expression than controls, while the medians (IQRs) of FOXCUT in HCC and HCV patients were (0.15 [0.04−0.52], 6.42 [2.49−10.10], respectively) that exhibited significantly lower expression than controls regarding HCC patients but significantly higher expression than controls regarding HCV patients. In comparing serum fold changes of NBAT‐1 and FOXCUT between HCC patients and HCV patients; we obtained significantly higher levels of target genes in HCV patients (p < 0.001) than in HCC patients. Also, a positive correlation was detected between NBAT‐1 and FOXCUT in HCC group (r = 0.262, p = 0.001) and in HCV group (r = 0.937, p < 0.001). Higher serum NBAT‐1 and FOXCUT were significantly associated with better clinical and laboratory data of the disease. Multivariate regression analysis showed that FOXCUT was an independent predictor for HCC among HCV patients (p < 0.001)
   
     
 
       

Author Related Publications

  • 2251, "Pleurodesis Using Bleomycin Ampoules, Doxycycline Capsules, and Povidone Iodine Solution in Patients with Malignant Pleural Effusion in Zagazig University Hospitals", Zagazig University, Faculty of Medicine, 2022 More
  • 2251, "Outcome of docetaxel in treatment of metastatic hormone-sensitive prostate cancer and correlation with hemoglobin, albumin, lymphocyte and platelets score", Termedia Publishing House Ltd., 2022 More
  • 2251, "The incidence and clinical characteristics of pulmonary embolism in oncologic patients", Springer, 2022 More
  • 2251, "Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer", Termedia Publishing House Ltd., 2023 More
  • 2251, "Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer", Oxford University Press, 2024 More

Department Related Publications

  • Heba Fekry Abdel Majid Taha, "SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance", Elsevier,science direct, 2018 More
  • Shereen Mostafa Saleh Elshorbagy, "prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study", PMID: 35506035, 2022 More
  • Rasha Mohamed Mostafa Hagag, "Prognostic Value of Snail-1and Beta-Catenin Immunostaining in Astrocytoma.", International Journal of Advanced Research (2016), Volume 4, Issue 4, 1055-1066, 2016 More
  • Rasha Mohamed Mostafa Hagag, "Immunohistochemical expressions of SQSTM1/p62, Beclin-1, and SOX4 in infiltrating duct carcinoma of the breast", Egyptian Journal of Pathology, 2016 More
  • Shereen Mostafa Saleh Elshorbagy, "Immunohistochemical expressions of SQSTM1/p62, Beclin-1, and SOX4 in infiltrating duct carcinoma of the breast", Egyptian Journal of Pathology, 2016 More
Tweet